{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T07:20:45Z","timestamp":1772954445459,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["0074491"],"award-info":[{"award-number":["0074491"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.isci.2025.113466","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T15:39:30Z","timestamp":1756741170000},"page":"113466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Current advances in diabetic neuropathy: Proteins as therapeutic targets"],"prefix":"10.1016","volume":"28","author":[{"given":"Gurjeet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salaha Osman","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9163-7730","authenticated-orcid":false,"given":"Alberto","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Okdahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Wegeberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7464-3354","authenticated-orcid":false,"given":"Tarunveer S.","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Stevns","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolai J.","family":"Wewer Albrechtsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitte","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troels Staehelin","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Legido-Quigley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7117-3756","authenticated-orcid":false,"given":"Karolina","family":"Sulek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.113466_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2025.113466_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.isci.2025.113466_bib3","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1002\/acn3.50892","article-title":"Genetics of diabetic neuropathy: Systematic review, meta-analysis and trial sequential analysis","volume":"6","author":"Zhao","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.isci.2025.113466_bib4","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s12035-016-9823-4","article-title":"Effects of Common Polymorphisms in the MTHFR and ACE Genes on Diabetic Peripheral Neuropathy Progression: a Meta-Analysis","volume":"54","author":"Wu","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.isci.2025.113466_bib5","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2522\/ptj.20080008","article-title":"Diabetes-related microvascular and macrovascular diseases in the physical therapy setting","volume":"88","author":"Cade","year":"2008","journal-title":"Phys. Ther."},{"key":"10.1016\/j.isci.2025.113466_bib6","series-title":"Diagnosis and Treatment of Painful Diabetic Peripheral Neuropathy","author":"Pop-Busui","year":"2022"},{"key":"10.1016\/j.isci.2025.113466_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4137\/BMI.S38440","article-title":"Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients","volume":"11","author":"Sherwani","year":"2016","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.isci.2025.113466_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1208441","article-title":"Advantages of omics approaches for elucidating metabolic changes in diabetic peripheral neuropathy","volume":"14","author":"Yako","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2025.113466_bib9","first-page":"1523","article-title":"Proteomics Applications in Health: Biomarker and Drug Discovery and Food Industry","volume":"17","author":"Amiri-Dashatan","year":"2018","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"key":"10.1016\/j.isci.2025.113466_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.14007","article-title":"An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines","volume":"22","author":"Selby","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.isci.2025.113466_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/life12071074","article-title":"Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes","volume":"12","author":"Smith","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.isci.2025.113466_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12974-023-02740-x","article-title":"Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies","volume":"20","author":"Vargas-Soria","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2025.113466_bib13","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2018.18472","article-title":"Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis","volume":"320","author":"Busse","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2025.113466_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.isci.2025.113466_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9524635","article-title":"Understanding Diabetic Neuropathy: Focus on Oxidative Stress","volume":"2020","author":"Pang","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.isci.2025.113466_bib16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jpain.2022.02.011","article-title":"Activation of 20-HETE Synthase Triggers Oxidative Injury and Peripheral Nerve Damage in Type 2 Diabetic Mice","volume":"23","author":"Haddad","year":"2022","journal-title":"J. Pain"},{"key":"10.1016\/j.isci.2025.113466_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070029","article-title":"20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway","volume":"8","author":"Eid","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113466_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/1744806919880643","article-title":"mTOR activation due to APPL1 deficiency exacerbates hyperalgesia via Rab5\/Akt and AMPK signaling pathway in streptozocin-induced diabetic rats","volume":"15","author":"He","year":"2019","journal-title":"Mol. Pain"},{"key":"10.1016\/j.isci.2025.113466_bib19","first-page":"1453","article-title":"Investigation of Antioxidant Markers in Diabetic Patients","volume":"76","author":"Adnan Khalaf","year":"2021","journal-title":"Arch. Razi Inst."},{"key":"10.1016\/j.isci.2025.113466_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2337\/db15-0835","article-title":"Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental Diabetic Neuropathy","volume":"65","author":"Freeman","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.isci.2025.113466_bib21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00125-022-05846-8","article-title":"Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy","volume":"66","author":"Maalmi","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.isci.2025.113466_bib22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12974-016-0625-4","article-title":"Targeting inflammation as a treatment modality for neuropathic pain in spinal cord injury: a randomized clinical trial","volume":"13","author":"Allison","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2025.113466_bib23","article-title":"The Effect of Yiqi Huoxue Tongluo Decoction on Spinal Cord Microglia Activation and ASK1-MKK3-p38 Signal Pathway in Rats with Diabetic Neuropathic Pain","volume":"2022","author":"Wang","year":"2022","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"10.1016\/j.isci.2025.113466_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/cen.14261","article-title":"Increased levels of inflammatory factors are associated with severity of polyneuropathy in type 1 diabetes","volume":"93","author":"Okdahl","year":"2020","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.isci.2025.113466_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41983-019-0080-0","article-title":"Tumor necrosis factor alpha in peripheral neuropathy in type 2 diabetes mellitus","volume":"55","author":"El Sheikh","year":"2019","journal-title":"Egypt. J. Neurol. Psychiatr. Neurosurg."},{"key":"10.1016\/j.isci.2025.113466_bib26","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3889\/oamjms.2019.646","article-title":"Role of Inflammation in the Pathogenesis of Diabetic Peripheral Neuropathy","volume":"7","author":"Ristikj-Stomnaroska","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"10.1016\/j.isci.2025.113466_bib27","article-title":"Recent Advancements in Epidural Etanercept for Pain Management in Radiculopathy: A Literature Review","volume":"15","author":"Joseph","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.isci.2025.113466_bib28","article-title":"Painful Diabetic Neuropathy Is Associated with Compromised Microglial IGF-1 Signaling Which Can Be Rescued by Green Tea Polyphenol EGCG in Mice","volume":"2022","author":"Chen","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.isci.2025.113466_bib29","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1097\/j.pain.0000000000001061","article-title":"High levels of cerebrospinal fluid chemokines point to the presence of neuroinflammation in peripheral neuropathic pain: a cross-sectional study of 2 cohorts of patients compared with healthy controls","volume":"158","author":"Backryd","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.isci.2025.113466_bib30","article-title":"The Involvement of Caspases in Neuroinflammation and Neuronal Apoptosis in Chronic Pain and Potential Therapeutic Targets","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2025.113466_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12974-016-0607-6","article-title":"Interleukin-6: an emerging regulator of pathological pain","volume":"13","author":"Zhou","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2025.113466_bib32","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1074\/jbc.RA118.002492","article-title":"The prostaglandin E2 receptor EP3 controls CC-chemokine ligand 2-mediated neuropathic pain induced by mechanical nerve damage","volume":"293","author":"Treutlein","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.113466_bib33","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00586-012-2183-5","article-title":"Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica","volume":"21","author":"Ohtori","year":"2012","journal-title":"Eur. Spine J."},{"key":"10.1016\/j.isci.2025.113466_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1399-6576.2008.01590.x","article-title":"Bupivacaine inhibits COX-2 expression, PGE2, and cytokine production in endotoxin-activated macrophages","volume":"52","author":"Huang","year":"2008","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.isci.2025.113466_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1742-2094-10-55","article-title":"Bilateral elevation of interleukin-6 protein and mRNA in both lumbar and cervical dorsal root ganglia following unilateral chronic compression injury of the sciatic nerve","volume":"10","author":"Dubovy","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2025.113466_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030881","article-title":"High-Mobility Group Box 1 Protein Signaling in Painful Diabetic Neuropathy","volume":"21","author":"Thakur","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.113466_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.intimp.2017.09.021","article-title":"Spinal CCL1\/CCR8 signaling interplay as a potential therapeutic target - Evidence from a mouse diabetic neuropathy model","volume":"52","author":"Zychowska","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2025.113466_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.198","article-title":"CCL-1 in the spinal cord contributes to neuropathic pain induced by nerve injury","volume":"4","author":"Akimoto","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2025.113466_bib39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.molimm.2016.08.006","article-title":"Role of interleukin-4, the chemokine CCL3 and its receptor CCR5 in neuropathic pain","volume":"77","author":"Sun","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.isci.2025.113466_bib40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fnmol.2019.00216","article-title":"T Cells as an Emerging Target for Chronic Pain Therapy","volume":"12","author":"Laumet","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.isci.2025.113466_bib41","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.3389\/fimmu.2019.03009","article-title":"Cytokines in Pain: Harnessing Endogenous Anti-Inflammatory Signaling for Improved Pain Management","volume":"10","author":"Vanderwall","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.113466_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2008.01.005","article-title":"Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients","volume":"195","author":"Backonja","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.isci.2025.113466_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbi.2014.08.010","article-title":"Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy","volume":"44","author":"Janes","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.isci.2025.113466_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuroscience.2015.01.059","article-title":"Transforming growth factor-beta in the red nucleus plays antinociceptive effect under physiological and pathological pain conditions","volume":"291","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.isci.2025.113466_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.917587","article-title":"Role of Transforming Growth Factor Beta in Peripheral Nerve Regeneration: Cellular and Molecular Mechanisms","volume":"16","author":"Ye","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.isci.2025.113466_bib46","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1016\/j.bmcl.2014.08.009","article-title":"20(S)-Ginsenoside Rh2 as aldose reductase inhibitor from Panax ginseng","volume":"24","author":"Fatmawati","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.isci.2025.113466_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031031","article-title":"Aldose Reductase and the Polyol Pathway in Schwann Cells: Old and New Problems","volume":"22","author":"Niimi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.113466_bib48","article-title":"Aldose reductase inhibitors for the treatment of diabetic polyneuropathy","volume":"2007","author":"Chalk","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"issue":"Suppl 1","key":"10.1016\/j.isci.2025.113466_bib49","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1016\/j.diabres.2007.01.069","article-title":"A long-term effect of epalrestat on motor conduction velocity of diabetic patients: ARI-Diabetes Complications Trial (ADCT)","volume":"77","author":"Matsuoka","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.isci.2025.113466_bib50","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.2337\/dc05-2370","article-title":"Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial","volume":"29","author":"Hotta","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2025.113466_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107479","article-title":"Glucoselysine, a unique advanced glycation end-product of the polyol pathway and its association with vascular complications in type 2 diabetes","volume":"300","author":"Yamaguchi","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.113466_bib52","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/mp.54.6.400","article-title":"The role of glycation in the pathogenesis of diabetic polyneuropathy","volume":"54","author":"King","year":"2001","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.isci.2025.113466_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053267","article-title":"Growth Associated Protein 43 Is Expressed in Skeletal Muscle Fibers and Is Localized in Proximity of Mitochondria and Calcium Release Units","volume":"8","author":"Guarnieri","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113466_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2337\/db07-0895","article-title":"Neuritin Mediates Nerve Growth Factor\u2013Induced Axonal Regeneration and Is Deficient in Experimental Diabetic Neuropathy","volume":"57","author":"Karamoysoyli","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.isci.2025.113466_bib55","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/s41467-021-22767-z","article-title":"Next generation plasma proteome profiling to monitor health and disease","volume":"12","author":"Zhong","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.113466_bib56","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20188792","article-title":"Mass spectrometry-based protein-protein interaction networks for the study of human diseases","volume":"17","author":"Richards","year":"2021","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.isci.2025.113466_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/proteomes8030014","article-title":"A Critical Review of Bottom-Up Proteomics: The Good, the Bad, and the Future of this Field","volume":"8","author":"Dupree","year":"2020","journal-title":"Proteomes"},{"key":"10.1016\/j.isci.2025.113466_bib58","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/pmic.201500449","article-title":"Advances in targeted proteomics and applications to biomedical research","volume":"16","author":"Shi","year":"2016","journal-title":"Proteomics"},{"key":"10.1016\/j.isci.2025.113466_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100577","article-title":"MS-Based Proteomics of Body Fluids: The End of the Beginning","volume":"22","author":"Bader","year":"2023","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.isci.2025.113466_bib60","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/j.pain.0000000000002391","article-title":"Mitochondrial calcium uniporter deletion prevents painful diabetic neuropathy by restoring mitochondrial morphology and dynamics","volume":"163","author":"George","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.isci.2025.113466_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21394-y","article-title":"Integrative multiomic analyses of dorsal root ganglia in diabetic neuropathic pain using proteomics, phospho-proteomics, and metabolomics","volume":"12","author":"Doty","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.113466_bib62","article-title":"Paeoniflorin Upregulates Mitochondrial Thioredoxin of Schwann Cells to Improve Diabetic Peripheral Neuropathy Indicated by 4D Label-Free Quantitative Proteomics","volume":"2022","author":"Yang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.isci.2025.113466_bib63","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10787-017-0339-y","article-title":"Nrf2: a potential therapeutic target for diabetic neuropathy","volume":"25","author":"Kumar","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.isci.2025.113466_bib64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5853\/jos.2018.03454","article-title":"Biomarker for Ischemic Stroke Using Metabolome: A Clinician Perspective","volume":"21","author":"Sidorov","year":"2019","journal-title":"J. Stroke"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225017274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225017274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:18:03Z","timestamp":1772914683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225017274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2589004225017274"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.113466","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current advances in diabetic neuropathy: Proteins as therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.113466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113466"}}